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Wakayama, JapanObjectives This study sought to investigate the relationship between the degree of microvascular
dysfunction assessed by a dual-sensor guidewire (pressure and Doppler velocity) and left ventricular
(LV) remodeling after successful primary percutaneous coronary intervention (PPCI) for a ﬁrst anterior
acute myocardial infarction (AMI).
Background Microvascular dysfunction after AMI is associated with progressive LV dilation.
Methods In 24 consecutive patients, the microvascular resistance index (MVRI) immediately after PPCI
was calculated as the ratio of the mean distal pressure to average peak ﬂow velocity during maximal
hyperemia. Cardiac magnetic resonance was performed to determine LV volumes at baseline and
8-month follow-up. LV remodeling was deﬁned as an increase in left ventricular end-diastolic volume
(LVEDV) of 20%.
Results In patients with an MVRI greater than the median value of 2.96 mm Hg$cm1$s, the LVEDV
increased signiﬁcantly from 117.1  20.7 ml at baseline to 146.5  21.4 ml (p ¼ 0.006) at 8 months,
whereas it did not change between baseline and 8 months (108.2  21.2 ml vs. 111.6  29.9 ml,
p ¼ 0.620) in patients with an MVRI 2.96 mm Hg$cm1$s. LV remodeling was more frequent in the
group with an MVRI >2.96 mm Hg$cm1$s (64% vs. 15%, p ¼ 0.033). Furthermore, there was a positive
correlation between MVRI and the percentage of increase or decrease in LVEDV (r ¼ 0.42, p ¼ 0.042).
Logistic regression analysis showed that MVRI was the strongest univariate predictor of LV remodeling.
The best cutoff value of MVRI was 2.96 mm Hg$cm1$s with a sensitivity of 78% and a speciﬁcity
of 73%.
Conclusions MVRI immediately after PPCI predicts LV remodeling in patients with reperfused anterior
AMI. (J Am Coll Cardiol Intv 2013;6:1046–54) ª 2013 by the American College of Cardiology
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1047Primary percutaneous coronary intervention (PPCI) for
ST-segment elevation myocardial infarction is the most
effective reperfusion strategy and improves survival by
limiting myocardial necrosis (1). Despite successful recan-
alization of the infarct-related artery, however, left ven-
tricular (LV) remodeling after acute myocardial infarction
(AMI) develops in a substantial proportion of patients
due to impaired microvascular reperfusion (2–5). LV
remodeling has been shown to be associated with the
development of heart failure and worse long-term clinical
outcomes (6). Although the extent of microvascular dys-
function (MVD) is an important determinant of
LV remodeling (7,8), predicting LV remodeling in the
acute setting of myocardial infarction remains difﬁcult
because of the known disparity between epicardial coronary
blood ﬂow and microvascular perfusion. We recently showed
that microvascular resistance index (MVRI) measured by a
dual-sensor (pressure and Doppler velocity) guidewire
immediately after PPCI in patients with anterior AMI was
a useful predictor of infarct size and the transmural extent of
infarction assessed by contrast-enhanced cardiac magnetic
resonance (CMR) (9). However, it is unclear whether this
index at the time of AMI reperfusion has an impact on
progressive LV dilation compared with widely used indexes of
microvascular reperfusion, such as myocardial blush grade,
ST-segment resolution, and so on.
The aim of this study was to investigate the relationship
between MVRI at the time of reperfusion and LV remod-
eling with serial CMR imaging in patients successfully
treated with PPCI for AMI.obstruction
MVRI = microvascular
resistance index
Pa = aortic pressure
Pd = distal pressure
PPCI = primary percutaneous
coronary intervention
TIMI = Thrombolysis In
Myocardial InfarctionMethods
Patient population. From July 2009 to July 2010, we
enrolled consecutive 30 patients after successful PPCI for
a ﬁrst anterior AMI within 12 h from the onset of symp-
toms. The diagnosis of AMI was based on: 1) chest pain
continuing for >30 min; 2) ST-segment elevation of 2
mm (0.2 mV) in at least 2 contiguous precordial leads; and
3) Thrombolysis In Myocardial Infarction (TIMI) ﬂow
grade of 0, 1, or 2 at the initial coronary angiography.
Successful PPCI was deﬁned as residual stenosis 30% of
the culprit lesion with TIMI ﬂow grade 3. We excluded
patients with previous myocardial infarction, left main
coronary artery disease (50% stenosis), renal insufﬁciency
(serum creatinine >1.5 mg/dl), and cardiogenic shock.
Patients were also excluded if the patient had absolute or
relative contraindications to magnetic resonance examina-
tion, such as a pacemaker, atrial ﬁbrillation, and claustro-
phobia and if the patient experienced any cardiac event
during 8-month follow-up. All of the patients gave written
informed consent for participation in this study. The study
complied with the Declaration of Helsinki.Study protocol. Cardiac catheterization was performed by
a percutaneous femoral approach with a 6-F guiding catheter.
All patients received oral aspirin (162 mg) and a bolus of
heparin (100 U/kg) before the procedure, and additional
heparin was given if the procedure lasted>90min tomaintain
an activated clotting time 250 s. An intracoronary bolus
injection of isosorbide dinitrate (1 to 2 mg) was administered
to obtain a high-quality angiogram and before hemodynamic
measurements. PPCI was performed by the standard manner
according to clinical guidelines at the time of the procedure.
After manual thrombus aspiration using an Export catheter
(Medtronic, Tokyo, Japan), balloon angioplasty was per-
formed, followed by bare-metal stent implantation. Except for
2 patients who had received ticlopidine for stroke prevention,
all patients were given a clopi-
dogrel loading dose of 300 mg
immediately after PPCI. After
coronary stenting, all patients
received dual antiplatelet therapy
with ticlopidine (200 mg/day)
or clopidogrel (75 mg/day) and
aspirin (100 mg/day) for at
least 30 days, followed by aspirin
alone indeﬁnitely. Myocardial
blush grade was determined from
the ﬁnal angiogram by 2 experi-
enced interventional cardiologists
(Y.I. and K.K.) blinded to the
MVRI result, as described previ-
ously (10). The ST-segment res-
olution was evaluated on a
12-lead electrocardiogram recor-
ded in the emergency department
and 1 h after PPCI. The sum
of ST-segment resolution was
measured 60 ms after J point in
leads I, aVL, and V1 to V6. The
percentage of resolution of ST-
segment elevation from before
to after PPCI was calculated.
Complete reperfusion was deﬁned as 70% ST-segment
resolution on electrocardiography (11). To determine peak
values of creatine kinase and creatine kinase-myocardial
band (CK-MB), blood samples were obtained on admission
and serially every 3 h for the ﬁrst 24 h after PPCI. CMR
was performed 11  3 days after the onset of AMI and at
8 months.
Hemodynamic measurements and data analysis. Aortic
pressure (Pa) was measured through the guiding catheter.
Immediately after PPCI, distal pressure (Pd), and ﬂow
velocity distal to the culprit site were measured simulta-
neously with a 0.014-inch dual-sensor guidewire (Combo-
Wire, Volcano Therapeutics, Rancho Cordova, California),
as reported previously (9). In brief, after the wire was
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1048calibrated, advanced through the catheter, and equal with
the Pa in the catheter, it was placed at least 3 to 4 cm distal
to the stented segment of the left anterior descending artery
and manipulated until an optimal and stable velocity signal
was obtained. The position of the tip of the wire was
conﬁrmed by ﬂuoroscopy and angiography. Pa, Pd, instan-
taneous peak velocity, and electrocardiogram were obtained
online at baseline and after induction of maximal hyperemia
with 150 mg/kg/min of intravenous adenosine triphosphate
via a central venous catheter (ComboMap Pressure and Flow
System, Volcano Therapeutics). Twenty minutes after
PPCI, all signals were digitally recorded on a personal
computer for ofﬂine analysis by an independent investigator
(M.K.) who was unaware of patient data. Fractional ﬂow
reserve was calculated by dividing the mean Pd by the mean
Pa during maximal hyperemia. Coronary ﬂow reserve (CFR)
was calculated as the ratio of time-averaged peak hyperemic
to baseline average peak ﬂow velocity. In 3 consecutive
cardiac cycles, the deceleration time of diastolic velocity (ms)
was measured from phasic coronary ﬂow velocity recording
as previously described (12) and averaged for the mean value.
MVRI was calculated as the ratio of the mean Pd to the
average peak ﬂow velocity during maximal hyperemia (9).
CMR protocol. All CMR examinations were performed with
a 1.5-T magnetic resonance scanner (Intera Achieva, Philips
Medical Systems, Best, the Netherlands) equipped with
a 5-element cardiac phased-array coil for signal reception, as
previously described (9,13). First, breath-hold cine steady-
state free precession images with a time resolution of 35 ms
were acquired. Next, a breath-hold 3-dimensional turbo
gradient echo with inversion recovery was used to obtain the
late enhanced images. Contiguous short-axis slices and
representative long-axis slices of the left ventricle were ob-
tained 10 min after intravenous injection of 0.1 mmol/kg
gadolinium-diethylenetriamine pentaacetic acid (Magnevist,
Schering AG, Berlin, Germany). Scan parameters were as
follows: repetition time, 4.1 ms; echo time, 1.25 ms; ﬂip
angle, 15; ﬁeld of view, 350  350 mm; partial echo;
matrix, 224  256; and spatial resolution, 1.56  2.24  10
mm3 reconstructed to 0.68  0.68  5 mm3. All images
were gated to the electrocardiogram and acquired during
breath-hold at end expiration. We optimized the inversion
time (200 to 300 ms) to null the normal myocardium. No
complications related to the CMR procedures occurred. All
24 patients studied tolerated the procedure well, and all
CMR scans were analyzable.
CMR data analysis and deﬁnitions. All CMR data were
analyzed by the consensus of 2 observers (T.T. and Y.O.)
who were blinded to clinical and hemodynamic data using
an ofﬂine work station (View Forum, Phillips, Best, the
Netherlands). Using a 17-segment model as previously
recommended by the American Heart Association (14),
myocardial necrosis was deﬁned as transmural if late
enhancement extended to >75% of the myocardial wallthickness in at least 2 contiguous LV segments among 16
segments except the apex. After the total volume of
enhanced tissue was determined, infarct size was expressed
as a percentage of LV volume as follows: volume of
enhanced tissue  100 O total volume of LV myocardium.
Microvascular obstruction (MVO) was deﬁned as any region
of hypoenhancement within the hyperenhanced infarcted
area on late enhanced images and was included in the
calculation of total infarct size. The LV volumes were
calculated by tracing the end-diastolic and end-systolic LV
slice contours using the modiﬁed Simpson’s rule method.
End-diastolic and end-systolic volumes were deﬁned as the
largest and the smallest LV cavity, respectively. Papillary
muscles were excluded from the volume measurements. LV
ejection fraction was calculated as: (left ventricular end-
diastolic volume [LVEDV]  LV end-systolic volume) O
LVEDV. The change in the LVEDV was evaluated as the
percentage of increase or decrease in LVEDV from baseline
to 8 months in each patient. LV remodeling was deﬁned as
an increase in LVEDV of 20%.
Statistical analysis. All statistical analyses were performed
with SPSS software for Windows version 11.0 (SPSS Inc.,
Chicago, Illinois). Data were expressed as mean  SD or
number (%). Categorical variables were compared by the
chi-square or Fisher exact test, as appropriate. Continuous
variables were compared with the use of an unpaired Student
t test. The paired-samples Student t test was used to
compare differences in LVEDV between baseline and
8-month follow-up. Pearson’s correlation coefﬁcient (r) was
calculated for the relationship between MVRI and the
percentage of increase or decrease in LVEDV. A univariate
logistic regression model was used to examine independent
associations between LV remodeling, MVRI, other param-
eters of coronary microcirculation (CFR, diastolic decelera-
tion time, myocardial blush grade, and ST-segment
resolution), pre-infarction angina, collaterals, peak CK-MB,
and CMR parameters (infarct size, transmural necrosis,
MVO, baseline LVEDV, baseline LV end-systolic volume,
and baseline LV ejection fraction). Unadjusted odds ratios
with their 95% conﬁdence intervals were computed.
Receiver-operating characteristic curve analysis was per-
formed to assess the best cutoff value of MVRI to predict
LV remodeling, using Medcalc (Medcalc Software, Maria-
kerke, Belgium). The optimal cutoff value was deﬁned as the
value with the highest sum of sensitivity and speciﬁcity.
Values of p < 0.05 were considered statistically signiﬁcant.
Results
Study population. Two of 30 patients were excluded from
the study because of exclusion criteria (cardiogenic shock
and atrial ﬁbrillation). One patient was hospitalized for heart
failure at 2 months. One patient underwent percutaneous
coronary intervention for a new lesion in the infarct-related
Table 1. Baseline Characteristics
MVRI
>2.96 (n ¼ 11) 2.96 (n ¼ 13) p Value
Age, yrs 66  10 69  9 0.448
Male 9 (82) 9 (69) 0.649
Coronary risk factors
Hypertension 7 (64) 8 (62) 1.000
Diabetes mellitus 4 (36) 4 (31) 1.000
Dyslipidemia 3 (27) 7 (54) 0.240
Current smoking 5 (45) 5 (38) 1.000
Family history of CAD 0 (0) 2 (15) 0.482
Pre-infarction angina 1 (9) 5 (38) 0.166
Killip classiﬁcation 0.530
1 9 (82) 12 (92)
2 1 (9) 1 (8)
3 1 (9) 0 (0)
Peak CK, IU/l 5,009  1,308 2,633  1,965 0.003
Peak CK-MB, IU/l 472  168 224  173 0.002
Baseline angiographic characteristics
Infarct location 0.368
Proximal LAD 8 (73) 6 (46)
Mid LAD 3 (27) 7 (54)
No. of diseased vessels 0.538
1 6 (55) 8 (62)
2 5 (45) 4 (31)
3 0 (0) 1 (8)
Collaterals, Rentrop grade 2 3 (27) 5 (38) 0.679
Time to reperfusion, min 256  128 234  144 0.699
Stent diameter, mm 3.4  0.4 3.3  0.5 0.599
Stent length, mm 18.9  3.6 19.7  3.7 0.596
Post-procedure outcomes
Transient slow ﬂow 4 (36) 2 (15) 0.357
Final TIMI ﬂow grade 3 11 (100) 13 (100) 1.000
Side branch occlusion 1 (9) 1 (8) 1.000
Distal emobolization 0 (0) 0 (0) d
Myocardial blush grade 0.205
0/1 8 (73) 5 (38)
2/3 3 (27) 8 (62)
Mean residual stenosis, % 6.6  1.7 5.7  2.0 0.253
ST-segment resolution 70% 2 (18) 8 (62) 0.047
Medication at discharge
ACE inhibitor/ARB 10 (91) 11 (85) 1.000
Spironolactone/eplerenone 1 (9) 0 (0) 0.458
Beta-blocker 7 (64) 9 (69) 1.000
Statin 5 (45) 10 (77) 0.206
Values are mean  SD or n (%).
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blocker; CAD ¼ coro-
nary artery disease; CK ¼ creatine kinase; CK-MB ¼ creatine kinase-myocardial band; LAD ¼ left
anterior descending artery; MVRI ¼ microvascular resistance index; TIMI ¼ Thrombolysis In
Myocardial Infarction.
Table 2. Hemodynamic Data
MVRI
>2.96 (n ¼ 11) 2.96 (n ¼ 13) p Value
Heart rate, beats/min 78  7 74  8 0.210
Systolic BP, mm Hg 121  16 115  10 0.275
Diastolic BP, mm Hg 77  14 69  12 0.146
CFR 1.33  0.32 1.70  0.55 0.062
b-APV, cm/s 19  5 23  7 0.128
h-APV, cm/s 23  7 38  14 0.004
DDT, ms 424  169 693  267 0.009
FFR 0.91  0.09 0.85  0.11 0.163
MVRI, mm Hg$cm1$s 3.53  0.39 2.01  0.75 <0.001
Values are mean  SD.
APV ¼ average peak ﬂow velocity; b ¼ baseline; BP ¼ blood pressure; CFR ¼ coronary ﬂow
reserve; DDT ¼ diastolic deceleration time; FFR ¼ fractional ﬂow reserve; h ¼ hyperemia;
MVRI ¼ microvascular resistance index.
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1049artery because of unstable angina at 3 months. Therefore,
these 2 patients were also excluded from the study. A further
2 patients were excluded from analysis for refusal of follow-
up CMR. Finally, 24 patients were analyzed. The medianMVRI value in these patients was 2.96 mm Hg$cm1$s.
According to this median value, patients were divided into 2
groups: >2.96 mm Hg$cm1$s (n ¼ 11) and 2.96
mm Hg$cm1$s (n ¼ 13).
Baseline characteristics. As summarized in Table 1, the
groups had similar baseline characteristics. The time to
reperfusion was not different between patients with high or
low MVRI. There were also no signiﬁcant differences
with respect to the use of angiotensin-converting enzyme
inhibitor/angiotensin II receptor blocker or a beta-blocker
between the 2 groups. However, peak CK and peak CK-MB
were signiﬁcantly higher in patients with a high MVRI
compared with those with a low MVRI. Normal myocardial
blush (grade 2) was observed in 3 patients (27%) in the
group with an MVRI >2.96 mm Hg$cm1$s and 8 patients
(62%) in the group with an MVRI 2.96 mm Hg$cm1$s.
The rate of complete ST-segment resolution was lower in
patients having values >2.96 mmHg$cm1$s (18% vs. 62%,
p ¼ 0.047).
Coronary angiography performed 8 months after AMI
demonstrated no signiﬁcant differences in the rate of
restenosis between groups (18% vs. 23%, p ¼ 1.000).
Hemodynamic data. Hemodynamic data are displayed in
Table 2. In patients with an MVRI >2.96 mm Hg$cm1$s,
CFR (1.33  0.32 vs. 1.70  0.55, p ¼ 0.062) was numer-
ically lower and diastolic deceleration time (424 169 ms vs.
693  267 ms, p ¼ 0.009) was signiﬁcantly shorter than in
patients with an MVRI 2.96 mm Hg$cm1$s. There was
no difference with regard to the post-procedure fractional
ﬂow reserve between groups. MVRI (3.53  0.39
mmHg$cm1$s vs. 2.01 0.75mmHg$cm1$s, p< 0.001)
were signiﬁcantly greater in patients having values >2.96
mm Hg$cm1$s.
CMR results. The CMR ﬁndings at baseline and 8 months
are summarized in Table 3. At baseline, infarct size in
the group with an MVRI >2.96 mm Hg$cm1$s was
Table 3. CMR Findings at Baseline and at 8 Months
MVRI
>2.96 (n ¼ 11) 2.96 (n ¼ 13) p Value
Baseline
Infarct size, % 30.2  8.7 18.3  12.7 0.016
LVEDV, ml 117.1  20.7 108.2  21.2 0.312
LVESV, ml 73.4  18.7 58.2  21.6 0.082
LVEF, % 37.8  9.6 48.1  10.7 0.022
MVO 7 (64) 2 (15) 0.033
Transmural necrosis 6 (55) 3 (23) 0.206
After 8 months
Infarct size, % 29.1  9.8 18.0  12.1 0.023
LVEDV, ml 146.5  21.4 111.6  29.9 0.004
LVESV, ml 86.7  21.7 62.6  28.8 0.033
LVEF, % 41.1  7.0 46.4  12.0 0.211
Values are mean  SD or n (%).
CMR ¼ cardiac magnetic resonance; LVEDV ¼ left ventricular end-diastolic volume; LVEF ¼
left ventricular ejection fraction; LVESV ¼ left ventricular end-systolic volume; MVO ¼ micro-
vascular obstruction; MVRI ¼ microvascular resistance index.
Kitabata et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 1 0 , 2 0 1 3
Relationship Between MVRI and LV Remodeling O C T O B E R 2 0 1 3 : 1 0 4 6 – 5 4
1050signiﬁcantly larger than that in the group with an MVRI
2.96 mm Hg$cm1$s (30.2  78.7% vs. 18.3  12.7%,
p ¼ 0.016). This initial signiﬁcant difference in infarct size
between groups was maintained at 8 months (29.1  9.8%
vs. 18.0  12.1%, p ¼ 0.023). Even though there were no
signiﬁcant differences in LVEDV and LV end-systolic
volume at baseline between the 2 groups, the LVEDV andFigure 1. Relationship Between % D LVEDV and MVRI
Comparison of increase or decrease in left ventricular end-diastolic volume (% D LV
resistance index (MVRI) >2.96 mm Hg$cm1$s and those presenting with an MVRI LV end-systolic volume at 8 months were signiﬁcantly
greater in the group with an MVRI >2.96 mm Hg$cm1$s.
At baseline, there was signiﬁcant lower LV ejection fraction
in patients with an MVRI >2.96 mmHg$cm1$s compared
with patients with an MVRI 2.96 mm Hg$cm1$s,
whereas no difference in LV ejection fraction after 8 months
between the 2 groups was observed. At baseline, MVO was
present in 7 (64%) of 11 patients with a high MVRI and in 2
(15%) of 13 patients with a low MVRI (p ¼ 0.033); no
patients demonstrated MVO at follow-up. The incidence of
transmural necrosis was not different between groups.
MVRI and LV remodeling. In patients with an MVRI >2.96
mm Hg$cm1$s, the LVEDV increased progressively from
117.1  20.7 ml at baseline to 146.5  21.4 ml (p ¼ 0.006)
at 8 months. In patients with an MVRI 2.96
mm Hg$cm1$s, the LVEDV did not change from baseline
to 8 months (108.2  21.2 ml vs. 111.6  29.9 ml, p ¼
0.620) (Fig. 1). The high MVRI group demonstrated
a greater change in the LVEDV than the low MVRI group
(27.7  23.8% vs. 3.3  19.6%, p ¼ 0.012). Furthermore,
as shown in Figure 2, a signiﬁcant positive correlation
was found between MVRI at the time of reperfusion and
percentage of increase or decrease in LVEDV (r ¼ 0.42,
p ¼ 0.042). Nine patients (38%) developed LV remodeling
at 8 months. LV remodeling was more frequently observed
in patients in whom the MVRI was greater than the median
value of 2.96 mm Hg$cm1$s (64% vs. 15%, p ¼ 0.033)
(Fig. 3). Simultaneous pressure and Doppler velocityEDV) from baseline to 8 months in patients presenting with a microvascular
2.96 mm Hg$cm1$s. *p ¼ comparison between groups of % D LVEDV.
Figure 2. Relationship Between MVRI and % D LVEDV
% D LVEDV is plotted against MVRI. There was a signiﬁcant positive correlation
between the 2 variables. Abbreviations as in Figure 1.
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1051measurements immediately after PPCI in representative
patients of reverse LV remodeling and progressive LV
remodeling are shown in Figures 4 and 5.
Predictor of LV remodeling. On univariate analysis, MVRI
measured immediately after PPCI was the only inde-
pendent predictor of the development of LV remodeling at
follow-up (odds ratio: 7.15; 95% conﬁdence interval [CI]:
1.20 to 42.6; p ¼ 0.031) (Table 4). Receiver-operating
characteristic curve analysis for MVRI showed an area
under the curve of 0.79 (95% CI: 0.57 to 0.93) (Fig. 6).Figure 3. Prevalence of LV Remodeling at 8 Months in Patients With
High Versus Low MVRI
LV remodeling was more frequent in the high MVRI group. LV ¼ left
ventricular; other abbreviations as in Figures 1 and 3.The best cutoff value was found to be 2.96
mm Hg$cm1$s. The sensitivity, speciﬁcity, and predictive
accuracy were 78%, 73%, and 75%, respectively.
Discussion
The main ﬁndings of this study were as follows: 1) LV
remodeling occurred in 38% of patients with a ﬁrst anterior
wall AMI despite early restoration of TIMI ﬂow grade 3; 2)
a high MVRI at the time of reperfusion was associated with
the development of LV remodeling at 8 months; and 3)
compared with other techniques for assessing MVD, such as
myocardial blush grade, ST-segment resolution, CFR, dia-
stolic deceleration time, and MVO, the degree of MVD
assessed by MVRI was the only signiﬁcant independent
predictor of LV remodeling.
Although the pathophysiological mechanisms of post-
infarction LV remodeling are multifactorial, the degree of
perfusion of the infarct-related artery is a major determinant
of LV volume change. Only patients with TIMI ﬂow 3
grade have been considered as having successful epicardial
perfusion (15). Despite successful recanalization of TIMI
ﬂow grade 3 in the infarct-related artery, however, LV
remodeling can occur in 20% to 32% of patients after AMI;
inadequate microvascular reperfusion is strongly associated
with a higher rate of LV remodeling (2–5). In the present
study, 38% of the entire study population experienced
adverse LV remodeling at 8 months. This rate is somewhat
high compared with the results of previous studies. This
discrepancy may be explained partly by the difference in the
performance of imaging modalities used (CMR vs. 2-
dimensional echocardiography) to assess the change in LV
volumes. CMR is currently considered the gold standard for
assessment of LV volumes (16), and its accuracy and high
reproducibility make this technique ideal for serial assess-
ment of LV remodeling (17,18). Another explanation could
be that our study included only patients with anterior AMI
undergoing PPCI to the left anterior descending artery.
However, when the results of MVRI measurement were
taken into account, progressive LV dilation was signiﬁcantly
higher in patients with a high MVRI (64%) than in those
with a low MVRI (15%). These rates of LV remodeling
are in good agreement with those reported by Bolognese
et al. (4). They used intracoronary myocardial contrast
echocardiography to assess the extent of MVD in 124
patients with a TIMI ﬂow grade 3 after PPCI. As a result,
LV remodeling was observed in 63% of patients with MVD
and 11% of patients without MVD, respectively. This
ﬁnding supports the concept that MVRI may have the
potential to distinguish patients in whom LV remodeling
develops from those in whom it does not.
A number of invasive and noninvasive techniques have
been proposed as methods for assessing the presence of
impaired microvascular perfusion in the setting of AMI.
Figure 4. Simultaneous Pressure and Doppler Velocity Measurements in a Representative Patient (a 75-Year-Old Woman) of Reverse LV Remodeling
This patient had an obstructed lesion in the proximal left anterior descending artery and was treated successfully with manual thrombus aspiration and stent
implantation. The time to reperfusion was 150 min. MVRI was calculated as 1.77 mm Hg$cm1$s. The LVEDV decreased signiﬁcantly from 107.1 ml at baseline to 76.9
ml at 8-month follow-up, with % D LVEDV of 28%. APV ¼ average peak ﬂow velocity; EDV ¼ end-diastolic volume; EF ¼ ejection fraction; ESV ¼ end-systolic volume;
Pd ¼ distal pressure; other abbreviations as in Figure 1.
Figure 5. Simultaneous Pressure and Doppler Velocity Measurements in a Representative Patient (a 65-Year-Old Woman) of
Progressive Left Ventricular Remodeling
After thrombectomy, an obstructed lesion in the proximal left anterior descending artery was treated successfully with stenting. The time to reperfusion was 157 min.
MVRI showed a high value of 3.36 mm Hg$cm1$s. The LVEDV increased progressively from 113.4 ml to 194.8 ml, with % D LVEDV of 72%. Abbreviations as in Figures 1,
3, and 4.
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Table 4. Univariate Logistic Regression Analysis for Predictors of
Left Ventricular Remodeling
OR 95% CI p Value
MVRI 7.15 1.20–42.6 0.031
CFR 0.33 0.05–2.23 0.256
DDT 1.00 0.99–1.00 0.058
Myocardial blush grade 2 0.19 0.03–1.25 0.084
ST-segment resolution >70% 0.57 0.10–3.18 0.523
Pre-infarction angina 0.79 0.11–5.49 0.806
Collaterals (Rentrop 2) 0.43 0.07–2.81 0.363
Peak CK-MB 1.00 1.00–1.01 0.144
Infarct size 1.02 0.95–1.10 0.507
Transmural necrosis 0.75 0.13–4.22 0.744
MVO 3.44 0.60–19.6 0.165
Baseline LVEDV 0.97 0.93–1.02 0.235
Baseline LVESV 0.98 0.94–1.02 0.390
Baseline LVEF 1.00 0.93–1.08 0.985
CI ¼ conﬁdence interval; OR ¼ odds ratio; other abbreviations as in Tables 1 to 3.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 1 0 , 2 0 1 3 Kitabata et al.
O C T O B E R 2 0 1 3 : 1 0 4 6 – 5 4 Relationship Between MVRI and LV Remodeling
1053Previous studies reported that myocardial blush grade and
ST-segment resolution provided important information
about LV dilation process beyond the standard TIMI ﬂow
grading (5,19). Garot et al. (3) reported that CFR assessed
early after reperfusion by using a Doppler guidewire was
a good predictor of LV remodeling. It has also beenFigure 6. Receiver-Operating Characteristic Curve Analysis of MVRI to
Predict Left Ventricular Remodeling
Receiver-operating characteristic curve analysis shows an area under
the curve (AUC) of 0.79 (95% conﬁdence interval [CI]: 0.57 to 0.93) and
a 2.96-mm Hg$cm1$s cutoff with a sensitivity of 78% and a speciﬁcity of
73% (red dot). Abbreviations as in Figure 1.demonstrated that the coronary ﬂow velocity pattern,
including diastolic deceleration time, immediately after
PPCI can predict LV dilation (20). In addition, MVO on
CMR was recently shown to predict LV remodeling (21,22).
However, as shown in this study, their predictive values in
the prediction of post-infarction LV remodeling were deﬁ-
nitely low compared with MVRI.
Study limitations. First, this study is limited by its small
sample size. Second, pre-infarction angina was frequent in
the low MVRI group (38% vs. 9%, p ¼ 0.166). Therefore,
the possibility that this may have had an inﬂuence on the
prevalence of LV remodeling and hemodynamic measure-
ments through recruitment of collaterals or ischemic pre-
conditioning of the myocardium cannot be excluded
necessarily. Third, because the size and extent of MVO were
not evaluated in the present study, we may have under-
estimated the full potential of MVO to predict LV
remodeling. Fourth, infarct size, which is predictive of the
development of LV dilation (23), was signiﬁcantly larger in
patients with a high MVRI. However, there were no
signiﬁcant differences in baseline infarct size by CMR
(27.9  7.4% vs. 22.5  14.3%, p ¼ 0.305) and peak
CK-MB (421  197 IU/l vs. 287  207 IU/l, p ¼ 0.132)
between patients with or without LV remodeling. Fifth, in
calculating MVRI, we used only distal coronary pressure
instead of the pressure gradient across the microvasculature
by subtracting central venous pressure from distal coronary
pressure. Therefore, the MVRI measured may have been
falsely greater than when central venous pressure had been
taken into consideration. Finally, although we measured
coronary pressure and ﬂow velocity 20 min after the last
balloon inﬂation, previous animal studies demonstrated that
the hyperemic reaction after the recanalization of occluded
coronary arteries may continue for several hours (24,25),
which may have affected our results.
Clinical implications. Even in the reperfusion era, LV
remodeling remains an important treatment target.
Measuring MVRI at the time of reperfusion may allow us to
determine patients who may beneﬁt from cell therapy to
promote myocardial repair (26) or adjunctive pharmacolog-
ical intervention to induce reverse remodeling (27).Conclusions
Coronary microvascular resistance index measured imme-
diately after successful reperfusion is a strong parameter of
microvascular damage for predicting post-infarction LV
remodeling in patients with anterior AMI.
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